Annovis Bio, Inc.
ANVS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001477845
No open-market purchases or sales by Annovis Bio, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $20.2M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Annovis Bio, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- 0 vs. Q2 2025
- Shares held
- 2.02M
- +212.6K (+11.7%) vs. Q2 2025
- Total value
- $4.19M
- +$260.0K (+6.6%) vs. Q2 2025
- New holders
- 5
- 10 more added
- Sold out
- 5
- 8 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 61 | $20.2M |
| Q1 2026 | 56 | $10.5M |
| Q4 2025 | 53 | $14.7M |
| Q3 2025 | 42 | $4.19M |
| Q2 2025 | 42 | $3.93M |
| Q1 2025 | 44 | $3.13M |
| Q4 2024 | 40 | $7.93M |
| Q3 2024 | 35 | $9.50M |
| Q2 2024 | 31 | $5.67M |
| Q1 2024 | 31 | $14.3M |
| Q4 2023 | 36 | $22.5M |
| Q3 2023 | 30 | $10.6M |
| Q2 2023 | 28 | $18.3M |
| Q1 2023 | 23 | $11.6M |
| Q4 2022 | 23 | $9.93M |
| Q3 2022 | 25 | $10.0M |
| Q2 2022 | 26 | $8.73M |
| Q1 2022 | 24 | $11.9M |
| Q4 2021 | 32 | $19.6M |
| Q3 2021 | 38 | $36.2M |
| Q2 2021 | 57 | $109.0M |
| Q1 2021 | 31 | $23.1M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Annovis Bio, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 145 | $300 | 0.00% | −10−6.5% | Reduced |
| Advisor Group Holdings, Inc. | 210 | $429 | 0.00% | −467−69.0% | Reduced |
| IFP Advisors, Inc | 210 | $435 | 0.00% | +100+90.9% | Added |
| Larson Financial Group LLC | 300 | $621 | 0.00% | 00.0% | Unchanged |
| Rise Advisors, LLC | 333 | $689 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 350 | $724 | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 360 | $745 | 0.00% | 00.0% | Unchanged |
| Bokf, NA | 555 | $1.15K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 633 | $1.31K | 0.00% | −25,684−97.6% | Reduced |
| Steward Partners Investment Advisory, LLC | 1,000 | $2.07K | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 1,000 | $2.07K | 0.00% | +1,000 | New |
| Tower Research Capital LLC (TRC) | 1,021 | $2.11K | 0.00% | +1,021 | New |
| DiNuzzo Private Wealth, Inc. | 1,000 | $2.31K | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 1,431 | $2.96K | 0.00% | −32−2.2% | Reduced |
| FNY Investment Advisers, LLC | 2,000 | $4.00K | 0.00% | +2,000 | New |
| Covestor Ltd | 2,339 | $5.00K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 4,091 | $8.00K | 0.00% | −14−0.3% | Reduced |
| Morgan Stanley | 7,389 | $15.3K | 0.00% | −4,805−39.4% | Reduced |
| Bryn Mawr Trust Co | 9,393 | $19.4K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 9,746 | $20.2K | 0.00% | 00.0% | Unchanged |
| Wealthspire Advisors, LLC | 10,000 | $20.7K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 10,511 | $21.8K | 0.00% | +10,511 | New |
| CWA Asset Management Group, LLC | 13,001 | $26.9K | 0.00% | −6,000−31.6% | Reduced |
| JPMorgan Chase & Co | 14,900 | $30.8K | 0.00% | 00.0% | Unchanged |
| First National Trust Co | 15,000 | $31.1K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 19,058 | $39.5K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 19,400 | $40.2K | 0.00% | 00.0% | Unchanged |
| Sterling Investment Advisors, Ltd. | 23,416 | $48.5K | 0.01% | 00.0% | Unchanged |
| XTX Topco Ltd | 28,854 | $59.7K | 0.00% | +28,854 | New |
| Lokken Investment Group LLC | 29,248 | $60.5K | 0.02% | +130.0% | Added |
| Group One Trading, L.P. | 34,627 | $71.7K | 0.00% | +2,958+9.3% | Added |
| HRT Financial LP | 37,579 | $77.0K | 0.00% | +27,074+257.7% | Added |
| State Street Corp | 38,435 | $79.6K | 0.00% | 00.0% | Unchanged |
| Wescott Financial Advisory Group, LLC | 41,607 | $86.1K | 0.01% | 00.0% | Unchanged |
| Greenwich Wealth Management LLC | 47,400 | $98.0K | 0.00% | +400+0.9% | Added |
| BlackRock, Inc. | 80,675 | $167.0K | 0.00% | 00.0% | Unchanged |
| Merit Financial Group, LLC | 81,316 | $168.3K | 0.00% | −10,000−11.0% | Reduced |
| Northern Trust Corp | 121,060 | $250.6K | 0.00% | +61,546+103.4% | Added |
| Citadel Advisors LLC | 174,345 | $360.9K | 0.00% | +145,019+494.5% | Added |
| Geode Capital Management, LLC | 184,154 | $381.3K | 0.00% | +867+0.5% | Added |
| Susquehanna International Group, LLP | 218,421 | $452.1K | 0.00% | +53,863+32.7% | Added |
| Vanguard Group Inc | 738,003 | $1.53M | 0.00% | +41,239+5.9% | Added |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −90,907−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −23,798−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,564−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −544−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −1−100.0% | Sold out |